Juan Martínez-Aguilar

Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy

M. Molloy, R. Clifton-Bligh, J. Martínez-Aguilar, 2016, Scientific Reports.

Label-free selected reaction monitoring enables multiplexed quantitation of S100 protein isoforms in cancer cells.

M. Molloy, J. Martínez-Aguilar, Juan Martínez-Aguilar, 2013, Journal of proteome research.

Quantitative mass spectrometry for colorectal cancer proteomics

Jenny H. L. Chik, M. McKay, M. Molloy, 2013, Proteomics. Clinical applications.

Complete quality analysis of commercial surface-active products by Fourier-transform near infrared spectroscopy.

J. Martínez-Aguilar, E. L. Ibarra-Montaño, Juan Martínez-Aguilar, 2007, Talanta.

Targeted Mass Spectrometry of S100 Proteins.

M. Molloy, J. Martínez-Aguilar, Juan Martínez-Aguilar, 2019, Methods in molecular biology.

A proteomic signature and potential pharmacological opportunities in the adaptive resistance to MEK and PI3K kinase inhibition in pancreatic cancer cells

Juan Martínez-Aguilar, Alain Aguilar-Valdés, Francisco González-Vela, 2023, Proteomics.

SWATH-MS proteomics of PANC-1 and MIA PaCa-2 pancreatic cancer cells allows identification of drug targets alternative to MEK and PI3K inhibition.

L. Noriega, A. Tovar, V. A. Sosa-Hernández, 2021, Biochemical and biophysical research communications.

DERIVING PRIMARY CANCER CELL CULTURES FOR PERSONALIZED THERAPY.

J. Esparza-López, M. Ibarra-Sánchez, Juan Martínez-Aguilar, 2019, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy

M. Molloy, R. Clifton-Bligh, Juan Martínez-Aguilar, 2016, Scientific Reports.

T E C H N I C a L a D V a N C E Open Access

M. Molloy, R. Clifton-Bligh, Juan Martínez-Aguilar, 2022 .

T E C H N I C a L a D V a N C E Open Access

M. Molloy, R. Clifton-Bligh, Juan Martínez-Aguilar, 2022 .